secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2026-04-23T23:59:59+00:00
Accession:  0001477932-26-002472
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NYSE American accepts VolitionRx compliance plan; shares continue trading until Aug 2027 review
--------------------------------------------------------------------------------

- Received non-compliance notice on Feb 6, 2026 for stockholders' equity deficiency (below $2M threshold).
- Compliance plan submitted by March 8, 2026; accepted by NYSE American on April 22, 2026.
- Company has until August 6, 2027 to regain compliance; subject to periodic NYSE American review.
- If plan progress insufficient or compliance not met by deadline, delisting proceedings may be initiated.
- No immediate impact on listing; common stock continues trading under symbol VNRX on NYSE American.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793226002472/0001477932-26-002472-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793226002472/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-002472

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer